General Motors Company GM and its joint venture delivered around 373,000 vehicles in China in the second quarter, down 29% year over year. Despite this overall decline, the Detroit-based automaker’s new energy vehicle sales rose 24% year over year, representing a record 38% of GM's overall China deliveries for the quarter. All of GM's brands in China saw significant declines. Buick deliveries were about 81,000, down from 136,000 in the previous year. Chevrolet delivered almost 10,000 vehicles, down year over year from 48,000. Cadillac delivered about 29,000 vehicles, down year over year from 55,000. SAIC-GM-Wuling Automobile, a joint venture between GM, SAIC Motor and Guangxi Auto, delivered 252,000 cars, down from 286,000 a year prior. For individual models, Buick's GL8 family and VELITE 6 EV sold nearly 20,000 and 17,000 units, respectively, and became the brand's best sellers. Cadillac's CT5 upscale sedan led its sales with more than 16,000 units. Chevrolet's Monza sedan was the automaker’s most popular model. GM also announced that the Tahoe full-size SUV, popular in the United States, will soon be available in China. General Motors and other U.S. automakers have been struggling in China amid increased price competition from local automakers. Zacks Rank & Key Picks GM currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the auto space are Blue Bird Corporation BLBD, Renault SA RNLSY and American Axle & Manufacturing Holdings, Inc. AXL, each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here. The consensus estimate for BLBD’s 2024 sales and earnings suggests year-over-year growth of 17.29% and 155.14%, respectively. EPS estimates for 2024 and 2025 have improved 63 cents and 69 cents, respectively, in the past 60 days. The Zacks Consensus Estimate for RNLSY’s 2024 sales and earnings suggests year-over-year growth of 20.78% and 62.43%, respectively. EPS estimates for 2024 and 2025 have improved 6 cents and 14 cents, respectively, in the past 30 days. The Zacks Consensus Estimate for AXL’s 2024 sales and earnings suggests year-over-year growth of 3.05% and 544.44%, respectively. EPS estimates for 2024 have moved up 5 cents in the past 60 days. The same for 2025 has moved up 20 cents in the past 30 days. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report American Axle & Manufacturing Holdings, Inc. (AXL):Free Stock Analysis Report General Motors Company (GM):Free Stock Analysis Report Blue Bird Corporation (BLBD):Free Stock Analysis Report RENAULT (RNLSY):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
General Motors (GM) Q2 China Sales Fall Amid Rising Competition
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...